Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
813 Combination of HexaBody-CD27 with PD-(L)1 blockade potentiates single-agent activity leading to enhanced human T-cell effector functions in vitro
Compose a Response to This Article
Other responses
No responses have been published for this article.
